Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery
High-density lipoprotein (HDL) and low-density lipoprotein (LDL), as human endogenous lipoprotein particles, have low toxicity, high selectivity, and good safety. They can avoid the recognition and clearance of human reticuloendothelial system. These synthetic lipoproteins (sLPs) have been attracted...
Main Authors: | , |
---|---|
Format: | Article |
Language: | English |
Published: |
Taylor & Francis Group
2017-11-01
|
Series: | Drug Delivery |
Subjects: | |
Online Access: | http://dx.doi.org/10.1080/10717544.2017.1384518 |
id |
doaj-35334deb10fa46b793ac942c6fd5c986 |
---|---|
record_format |
Article |
spelling |
doaj-35334deb10fa46b793ac942c6fd5c9862020-11-24T21:50:06ZengTaylor & Francis GroupDrug Delivery1071-75441521-04642017-11-01242162110.1080/10717544.2017.13845181384518Synthetic lipoprotein as nano-material vehicle in the targeted drug deliveryXueqin Zhang0Gangliang Huang1Chongqing Normal UniversityChongqing Normal UniversityHigh-density lipoprotein (HDL) and low-density lipoprotein (LDL), as human endogenous lipoprotein particles, have low toxicity, high selectivity, and good safety. They can avoid the recognition and clearance of human reticuloendothelial system. These synthetic lipoproteins (sLPs) have been attracted extensive attention as the nanovectors for tumor-targeted drug and gene delivery. Herein, recent advances in the field of anticancer based on these two lipid proteins and recombinant lipoproteins (rLPs) as target delivery vectors were analyzed and discussed.http://dx.doi.org/10.1080/10717544.2017.1384518High-density lipoproteinlow-density lipoproteinrecombinant lipoproteinnano-scaled vehiclestargeted drug delivery |
collection |
DOAJ |
language |
English |
format |
Article |
sources |
DOAJ |
author |
Xueqin Zhang Gangliang Huang |
spellingShingle |
Xueqin Zhang Gangliang Huang Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery Drug Delivery High-density lipoprotein low-density lipoprotein recombinant lipoprotein nano-scaled vehicles targeted drug delivery |
author_facet |
Xueqin Zhang Gangliang Huang |
author_sort |
Xueqin Zhang |
title |
Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery |
title_short |
Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery |
title_full |
Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery |
title_fullStr |
Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery |
title_full_unstemmed |
Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery |
title_sort |
synthetic lipoprotein as nano-material vehicle in the targeted drug delivery |
publisher |
Taylor & Francis Group |
series |
Drug Delivery |
issn |
1071-7544 1521-0464 |
publishDate |
2017-11-01 |
description |
High-density lipoprotein (HDL) and low-density lipoprotein (LDL), as human endogenous lipoprotein particles, have low toxicity, high selectivity, and good safety. They can avoid the recognition and clearance of human reticuloendothelial system. These synthetic lipoproteins (sLPs) have been attracted extensive attention as the nanovectors for tumor-targeted drug and gene delivery. Herein, recent advances in the field of anticancer based on these two lipid proteins and recombinant lipoproteins (rLPs) as target delivery vectors were analyzed and discussed. |
topic |
High-density lipoprotein low-density lipoprotein recombinant lipoprotein nano-scaled vehicles targeted drug delivery |
url |
http://dx.doi.org/10.1080/10717544.2017.1384518 |
work_keys_str_mv |
AT xueqinzhang syntheticlipoproteinasnanomaterialvehicleinthetargeteddrugdelivery AT ganglianghuang syntheticlipoproteinasnanomaterialvehicleinthetargeteddrugdelivery |
_version_ |
1725885352955084800 |